OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of GBP 774.45 million. The enterprise value is 762.08 million.
| Market Cap | 774.45M |
| Enterprise Value | 762.08M |
Important Dates
The next estimated earnings date is Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 767.70M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.26% |
| Shares Change (QoQ) | -1.03% |
| Owned by Insiders (%) | 41.90% |
| Owned by Institutions (%) | 24.79% |
| Float | 348.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.62 |
| PB Ratio | 0.80 |
| P/TBV Ratio | 11.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.68 |
| EV / Sales | 1.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.83 |
Financial Position
The company has a current ratio of 3.70, with a Debt / Equity ratio of 0.30.
| Current Ratio | 3.70 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.86 |
| Interest Coverage | -1.88 |
Financial Efficiency
Return on equity (ROE) is -13.32% and return on invested capital (ROIC) is -7.23%.
| Return on Equity (ROE) | -13.32% |
| Return on Assets (ROA) | -6.15% |
| Return on Invested Capital (ROIC) | -7.23% |
| Return on Capital Employed (ROCE) | -11.45% |
| Revenue Per Employee | 159,379 |
| Profits Per Employee | -44,779 |
| Employee Count | 2,997 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 8.37 |
Taxes
In the past 12 months, OPKO Health has paid 15.54 million in taxes.
| Income Tax | 15.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.80% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -13.80% |
| 50-Day Moving Average | 1.40 |
| 200-Day Moving Average | 1.43 |
| Relative Strength Index (RSI) | 51.85 |
| Average Volume (20 Days) | 5,897 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 12.42 |
Income Statement
In the last 12 months, OPKO Health had revenue of GBP 477.66 million and -134.20 million in losses. Loss per share was -0.18.
| Revenue | 477.66M |
| Gross Profit | 90.42M |
| Operating Income | -155.56M |
| Pretax Income | -118.66M |
| Net Income | -134.20M |
| EBITDA | -86.16M |
| EBIT | -155.56M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 306.48 million in cash and 294.17 million in debt, giving a net cash position of 12.31 million.
| Cash & Cash Equivalents | 306.48M |
| Total Debt | 294.17M |
| Net Cash | 12.31M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 971.21M |
| Book Value Per Share | 1.26 |
| Working Capital | 340.58M |
Cash Flow
In the last 12 months, operating cash flow was -146.58 million and capital expenditures -11.18 million, giving a free cash flow of -157.76 million.
| Operating Cash Flow | -146.58M |
| Capital Expenditures | -11.18M |
| Free Cash Flow | -157.76M |
| FCF Per Share | n/a |
Margins
Gross margin is 18.93%, with operating and profit margins of -32.57% and -28.10%.
| Gross Margin | 18.93% |
| Operating Margin | -32.57% |
| Pretax Margin | -24.84% |
| Profit Margin | -28.10% |
| EBITDA Margin | -18.04% |
| EBIT Margin | -32.57% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.26% |
| Shareholder Yield | -2.26% |
| Earnings Yield | -17.33% |
| FCF Yield | -20.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.41 |
| Piotroski F-Score | 2 |